Provided by Tiger Trade Technology Pte. Ltd.

Martin Marietta Materials

591.49
+2.070.35%
Volume:12.35K
Turnover:7.25M
Market Cap:35.67B
PE:31.52
High:592.39
Open:582.81
Low:582.81
Close:589.42
52wk High:710.97
52wk Low:441.95
Shares:60.31M
Float Shares:59.82M
Volume Ratio:0.30
T/O Rate:0.02%
Dividend:3.24
Dividend Rate:0.55%
EPS(TTM):18.77
EPS(LYR):18.77
ROE:10.16%
ROA:4.99%
PB:3.56
PE(LYR):31.52

Loading ...

Martin Marietta Materials Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 22

Martin Marietta Materials Inc. to Release Fourth-Quarter and Full-Year Earnings Results

Reuters
·
Jan 22

Martin Marietta Materials Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jan 21

Martin Marietta Materials Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jan 17

B. Riley Initiates Coverage on Martin Marietta Materials With Neutral Rating, $700 Price Target

MT Newswires Live
·
Jan 16

Martin Marietta Initiated at Neutral by B. Riley Securities

Dow Jones
·
Jan 16

Martin Marietta initiated with a Neutral at B. Riley

TIPRANKS
·
Jan 16

Martin Marietta Materials Inc. Stock Slides 4.4%, Underperforms Market

Dow Jones
·
Jan 15

Martin Marietta Materials Shares Fall After DA Davidson Downgrade

MT Newswires Live
·
Jan 15

Martin Marietta Materials on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Jan 15

Martin Marietta price target raised to $700 from $643 at BofA

TIPRANKS
·
Jan 14

Martin Marietta Materials' Product Pricing Under Pressure -- Market Talk

Dow Jones
·
Jan 14

Martin Marietta Cut to Neutral From Buy by DA Davidson

Dow Jones
·
Jan 14

Martin Marietta cut to Neutral at DA Davidson after recent gains

TIPRANKS
·
Jan 14

Martin Marietta Materials Inc : D.a. Davidson Cuts to Neutral From Buy

THOMSON REUTERS
·
Jan 14

DA Davidson Downgrades Martin Marietta Materials to Neutral From Buy, Price Target is $690

MT Newswires Live
·
Jan 14

Martin Marietta Materials Inc. Stock Advances 4.5%, Outperforms Market

Dow Jones
·
Jan 10

BUY Rating on Palvella Therapeutics: De-Risked SELVA Phase 3 Design Positions QTORIN Rapamycin for First-in-Class MLM Approval and Compelling Risk–Reward

TIPRANKS
·
Jan 10

Martin Marietta Is Maintained at Buy by Citigroup

Dow Jones
·
Jan 09

Citigroup Adjusts Martin Marietta Materials Price Target to $758 From $754, Maintains Buy Rating

MT Newswires Live
·
Jan 09